Creyon Bio
PrivateLast Round
Strategic
Apr 29, 2025
Total Funding Raised
$40M
Company Overview
Creyon Bio operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Strategic round in April 2025.
Creyon Bio is a biotechnology company that develops RNA-based medicines and their components using a data-first approach with machine learning models.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Creyon Bio Comparables
Compare Creyon Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atomic AI | 87% | |
| Deep Genomics | 87% | |
| Genetic Leap | 86% |
For institutional investors. Book with your work email.
Creyon Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 29, 2025 | ||||
| Seed | Mar 8, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Creyon Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DCVC Bio | Seed |
| Lux Capital | Seed |
| Alexandria Venture Investments | Seed |
| BioBrit | Seed |
| Casdin Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2025
Completed a strategic funding round.
- Mar 8, 2022
$40M raised in Seed round.
For institutional investors. Book with your work email.
Creyon Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Creyon Bio's valuation, stock price, and market status.
Is Creyon Bio a public or private company?
Creyon Bio is a private company.
What is the current stock price of Creyon Bio?
Creyon Bio is a private company, so its shares have no public market price. Caplight tracks Creyon Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Creyon Bio worth (valuation)?
Valuation information for Creyon Bio is not publicly available.
Can I buy Creyon Bio stock?
Creyon Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Creyon Bio's last funding round?
Creyon Bio's most recent funding round was Strategic on April 29, 2025.
Who are the main investors in Creyon Bio?
Key investors in Creyon Bio include DCVC Bio, Lux Capital.
Will Creyon Bio IPO soon?
No public IPO plans have been announced for Creyon Bio.
How can I track Creyon Bio secondary market activity?
Caplight tracks bids, offers, and trades in Creyon Bio's shares on secondary markets.